Mobile Logo in White

Pertsemlidis Lab

Dr. Pertsemlidis and staff

Alexander Pertsemlidis, PhD

Rank: Professor
Department: Pediatrics, Cell Systems & Anatomy
Office: 3.100.22
Tel: 210-562-9062
pertsemlidis@uthscsa.edu

Our research interests integrate computational biology, cancer biology, and genetics. We are studying regulatory RNA molecules called non-coding RNAs (called that because they do not code for proteins), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), and how they regulate cancer cell growth and response to anti-cancer drugs.

Our Beliefs:

  • nature has already developed elegant but non-obvious solutions to most problems facing modern medicine
  • there may be many different solutions to the same problem
  • things that look the same at the tissue level may look very different at the molecular level

Our Goals:

  • develop sensitive, non-invasive methods for early cancer detection
  • identify new drugs targeting specific adult and pediatric cancer subtypes, either directly or in combination with traditional therapeutic agents

Our Projects:

  • ncRNA regulation of cell viability and drug response in neuroblastoma
  • Trisomy 21 and protection against neuroblastoma
  • Therapeutic miRNAs in combination with conventional chemotherapy
  • Molecular sensors for detecting cancer at the single-cell level
  • Separating tumor and host miRNAs through TU-tagging
  • Therapeutic regulation of the PI3K and Wnt signaling pathways

Our Results:

  • miRNA, lncRNA, and mRNA expression signatures of cancer cells and normal cells
  • interaction networks between miRNAs, lncRNAs, and mRNAs
  • ncRNAs and their regulatory targets characterized in vitro, in vivo, and silico
  • functional relationships between ncRNAs and disease
  • candidate biomarkers, therapeutic targets, and therapeutic agents.
Alexander Pertsemlidis, PhD, UT Health San Antonio Faculty Profile

Lab Research

Lab Staff

Seth Lawson
Research Assistant, Sr.

Michael Losiewicz, PhD
Visiting Scientist

Yiqiang Zhang, PhD
Research Scientist

Featured News

Pertsemlidis Lab Awarded American Lung Association Grant to Study “Identifying Exploitable Biomarkers of Lung Cancer Metastasis”

Nature Communications: Integrative transcriptome and chromatin landscape analysis reveals distinct epigenetic regulations in human memory B cells (Pertsemlidis)

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

Alexander Pertsemlidis, PhD Co-Awarded National Science Foundation Grant.

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

News

Advanced Science: Biosecurity Primitive: Polymerase X-based Genetic Physical Unclonable Functions (Pertsemlidis)
June 18, 2025

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

SLAS Discovery: The History, Landscape, and Outlook of Human Cell Line Authentication and Security (Pertsemlidis)
November 20, 2024

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

Nucleic Acids Research: TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells (Sung, Gupta, Pertsemlidis, Bishop, et al)
November 29, 2023

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

All news